Glycolysis is a central metabolic pathway for tumor cells. However, the potential roles of glycolysisrelated genes in renal cell carcinoma (RCC) have not been investigated. The glycolysis-related risk signature is closely associated with RCC prognosis, progression and immune microenvironment. CD44, PLOD1 and PLOD2 may serve as RCC oncogenes. |